Skip to content
Joe - ChimeraResearchGroup· @ChimeraResearch · X·· 2026-04-21Score60
Body

$MDNAF $MDNA.to outstanding data MDNA113 in NHP presented at #AACR26

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

Heat 14 · 12 likes · 0 replies · 2 reposts

Conference abstracts

Source: Joe - ChimeraResearchGroup · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org